Acyclovir NDC 71335-3103

Product information

Brand name (proprietary)

Acyclovir

Generic name (nonproprietary)

acyclovir

Active ingredients

Acyclovir — 400 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Bryant Ranch Prepack

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 210401

Marketing start

Jun 20, 2023

Listing expires

Dec 31, 2027

Other FDA classes

DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)

Identifiers

Product ID 71335-3103_465aaa54-8e0b-4a0e-9ea0-7f01ba2a6152SPL ID 465aaa54-8e0b-4a0e-9ea0-7f01ba2a6152SPL set ID 69e5455e-d0be-4c2b-b9ab-458b5480ed57RxCUI 197311UNII X4HES1O11F

Pharmacologic class

Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335310300 followed by a unit qualifier and the quantity Copy

Package 71335-3103-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 210401

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.